Oncology patients' weakened immune system can prevent body 'overreacting' to virus, say Haifa researchers; theory still to be tested, but already published in peer-reviewed journal

ONCOHOST, founded by the Technion's Yuval Shaked, is performing clinical trials; goal is to predict treatments' effectiveness and determine how to improve them, for each patient